{
    "code": "02020572",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020572",
    "time": "2020-02-25 12:29:24",
    "許可證字號": "衛署藥輸字第020572號",
    "註銷狀態": "已註銷",
    "註銷日期": "93\/08\/11",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "93\/08\/02",
    "發證日期": "83\/08\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202057201",
    "中文品名": "比效新靜脈輸注液４００公絲\/１２５公撮",
    "英文品名": "PEFLACINE 400MG\/125ML INJECTABLE SOLUTION FOR INFUSION",
    "適應症": "成人嚴重感染症，由革蘭氏陰性菌及葡萄球菌引起者。",
    "劑型": "270注射劑",
    "包裝": "注射袋 盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "89\/10\/05",
    "主成分略述": "PEFLOXACINE MESYLATE DIHYDRATE",
    "限制項目": "02輸　入",
    "申請商名稱": "1424601100  臺灣安萬特藥品股份有限公司",
    "申請商地址": "台北巿敦化南路一段１０８號９樓",
    "主製造廠": [
        {
            "製造廠名稱": "FFR0171000  HAUPT PHARMA LIVRON",
            "製造廠廠址": "1 RUE COMTE DE SINARD 26250-LIVRON FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812700808",
            "成分名稱": "PEFLOXACINE MESYLATE DIHYDRATE",
            "含量描述": "558.5",
            "含量": "558.5000000000",
            "單位": "MG"
        }
    ]
}